Manual of Clinical Nutrition

Medical Nutrition Therapy for Disorders of Lipid Metabolism

Manual of Clinical Nutrition Management C- 51 Copyright © 20 13 Compass Group, Inc.

References

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation,
   and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.


2. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
   Final Report. 2002. NIH publication No. 02-5215. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf.
   Accessed December 17, 2002.


3. AHA Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition
   Committee. Circulation. 2006;114:82-96.


4. Grundy SM, Cleeman JI, Merz CN, Brewer B, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ for the Coordinating
   Committee of the National Cholesterol Education Program. Implications of recent trials for the National Cholesterol Education
   Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.


5. Disorders in Lipid Metabolism Evidence-Based Nutrition Practice Guideline. Academy of Nutrition and Dietetics Evidence Analysis
   Library. Academy of Nutrition and Dietetics; 2011. Available at: http://www.andevidencelibrary.com. Accessed January 24, 2013.


6. Hegsted DM, Ausman LM, Johnson JA, Dallal GE. Dietary fat and serum lipids: an evaluation of the experimental data [published
   erratum appears in Am J Clin Nutr. 1993;58:245]. Am J Clin Nutr. 1993;57:875-883.


7. Kennedy ET, Bowman SA, Spence JT, Freedman M, King J. Popular diets: correlation to health, nutrition, and obesity. J Am Diet Assoc.
   2001;101:411-420.


8. Kris-Etherton PM, Pearson TA, Wan Y, Hargrove RL, Moriarity K, Fishell V, Etherton TD. High-monounsaturated fatty acid diets lower
   both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr. 1999;70:1009-1015.


9. Kasim-Karakas SE, Almario RU, Mueller WM, Peerson J. Changes in plasma lipoproteins during low-fat, high-carbohydrate diets:
   effects of energy intake. Am J Clin Nutr. 2000;71:1439-1447.


10. Stone NJ, Nicolosi R, Kris-Etherton P, Ernst ND, Krauss RM, Winston M. Summary of the scientific conference on the efficacy of
    hypocholesterolemic dietary interventions. Circulation. 1996;94:3388-3391.


11. De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of
    cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779-785.


12. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and
    mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther.
    1997;1:485-491.


13. Von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a
    randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;130:554-562.


14. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial
    infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455.


15. Harris WS. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S-1654S.


16. Kwiterovich PO. The effect of dietary fat, antioxidants, and pro-oxidants on blood lipid, lipoproteins, and atherosclerosis. J Am Diet
    Assoc. 1997;97:S31-S41.


17. Kris-Etherton PM. AHA Science Advisory: monounsaturated fatty acids and risk of cardiovascular disease. American Heart
    Association Nutrition Committee. Circulation. 1999;100:1253-1258.


18. St Jeor ST, Ashley JM. Dietary strategies: issues of diet composition. In: Fletcher GF, Grundy SM, Hayman LL, eds. Obesity: Impact on
    Cardiovascular Disease. Armonk, NY: Futura Publishing Co Inc; 1999: 233-246.


19. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med.
    1995;333:276-282.


20. Baum JA, Teng H, Erdman JW Jr, Weigel RM, Klein BP, Perskey WW, Freels S, Surya P, Bakhit RM, Ramos E, Shay NF, Potter SM, et al.
    Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density lipoprotein receptor
    messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr. 1998; 68:545-551.


21. Crouse JR III, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL. A randomized trial comparing the effect of casein with that of soy
    protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med.
    1999;159:2070- 207 6.


22. Tonstad S, Smerud K, Hoie L. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and
    plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr. 2002;76:78-84.


23. Position of the American Dietetic Association: Health implications of dietary fiber. J Am Diet Assoc. 2008;108:1716-1731.


24. Kritchevsky SB, Tell GS, Shimakawa T, Dennis B, Li R, Kohlmeier L, Steere E, Heiss G. Provitamin A carotenoid intake and carotid
    artery plaques: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr. 1998;68:726-733.


25. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in
    postmenopausal women. N Engl J Med. 1996;334:1156- 1 162.


26. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart
    disease in men. N Eng J Med. 1993;328:1450-1456.


27. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary heart
    disease in women. N Engl J Med. 1993;328:1444-1449.


28. Morton SP, Hardy M. Effect of Supplemental Antioxidants Vitamin C, Vitamin E, and Coenzyme Q10 for the Prevention and Treatment of
    Cardiovascular Disease. Evidence Report/Technology Assessment No. 83 (Prepared by Southern California-RAND Evidence-based
    Practice Center). Rockville, MD: Agency for Healthcare Research and Quality; 2003. AHRQ publication No. 03-E043.


29. Tribble DA. AHA Science Advisory: antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and
    beta-carotene: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;99:591-595.


30. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation
    may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.


31. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR, HOPE and HOPE-TOO
    Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled
    trial. JAMA. 2005;293:1338-1347.


32. Stephens NG, Parsons A, Scholfield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with
    coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.


33. Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC; HOPE Study; MICRO-HOPE Study.
    Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: Results of the HOPE study and
    the MICRO-HOPE substudy. Diabetes Care. 2002;25:1919-1927.


34. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-
    analysis of randomized trials. Lancet. 2003;361: 2017-2023.